Eleventh WHO/UNICEF consultation with OPV/IPV manufacturers and NRAs, 25 October 2012.
Presentations from the consultation meeting are available below.
-
Polio emergency and endgame. Timelines and strategies.
pdf, 1.21Mb -
Sabin-IPV, development, clinical trials and optimization
pdf, 1.85Mb -
PATH’s work to apply adjuvants to inactivated poliovirus vaccine
pdf, 611kb -
Projected global requirements for oral and inactivated poliovirus vaccine 2013 - 2018
pdf, 458kb -
Regulatory issues and pathways for intra dermal (ID) inactivated polio vaccine (IPV) and new intra muscular (IM) products (adjuvanted IM IPV)
pdf, 868kb -
Update: GPEI program to develop affordable IPV
pdf, 1.28Mb -
Progress toward a low COGs PER.C6® based IPV
pdf, 892kb -
UNICEF procurement and supply updates for OPV
pdf, 908kb -
Containment of polio viruses
pdf, 916kb -
Needle-free devices – latest developments
pdf, 2.21Mb